Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Carolina P ReyesInstituto Universitario de Bio-Orgánica Antonio González, Departamento de Bioquímica Microbiología, Biología Celular y Genética, Universidad de La Laguna, Av. Astrofísico Francisco Sánchez 2, 38206 La Laguna, Spain.ORCID 0000-0002-2117-8794
Alejandro ArdilesDepartamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomás, Avenida Iquique, Antofagasta 3991, Chile.ORCID 0000-0002-7188-6342
Laura Anaissi-AfonsoUnidad de Investigación, Hospital Universitario Ntra Sra de Candelaria, Ctra del Rosario 145, 38010 Santa Cruz de Tenerife, Spain.
Aday González-BakkerInstituto Universitario de Bio-Orgánica Antonio González, Universidad de La Laguna, Av. Astrofísico Francisco Sánchez 2, 38206 La Laguna, Spain.ORCID 0000-0002-9792-5194
José M PadrónInstituto Universitario de Bio-Orgánica Antonio González, Universidad de La Laguna, Av. Astrofísico Francisco Sánchez 2, 38206 La Laguna, Spain.ORCID 0000-0001-6268-6552
Ignacio A JiménezInstituto Universitario de Bio-Orgánica Antonio González, Departamento de Química Orgánica, Universidad de La Laguna, Av. Astrofísico Francisco Sánchez 2, 38206 La Laguna, Spain.
Félix MachínUnidad de Investigación, Hospital Universitario Ntra Sra de Candelaria, Ctra del Rosario 145, 38010 Santa Cruz de Tenerife, Spain.ORCID 0000-0003-4559-7798
Isabel L BazzocchiInstituto Universitario de Bio-Orgánica Antonio González, Departamento de Química Orgánica, Universidad de La Laguna, Av. Astrofísico Francisco Sánchez 2, 38206 La Laguna, Spain.ORCID 0000-0002-7698-2704
Funding
ACIISI ProID2017010167FIISC PIFIIS19/04MCIN MCIN/AEI/10.13039/501100011033/FEDER, UE (PID2022-136549OB-100 Project)Spanish Government (Project PID2021-123059OB-I00 funded by MCIN/AEI /10.13039/501100011033 / FEDER, UE).Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033; BFU2017-83954-R and PID2021-123716OB-I100
6 · The paper itself
Abstract
To explore new compounds with antitumour activity, fifteen phenolic
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Exploring the Anticancer Potential of Phenolic · full record | OpenQuestion